Description:

Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940) Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7E26385C-8CD8-C34F-E040-BB89AD434A8D

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7E26385C-8CD8-C34F-E040-BB89AD434A8D

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Kidney Cancer NCT01120249 Response - Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940) - 2998562v1.0

Instructions: Please submit at protocol specified intervals and at time of recurrence. All dates are MONTH, DAY, YEAR. Place an X in appropriate boxes. Circle AMENDED items in red and write AMENDED across the top of the form

Header
Clinical Assessment
Has the patient had a documented clinical assessment for this cancer? (during this report period)
Symptomatic Deterioration
Notice Of Recurrence
Has the patient been diagnosed with recurrence of disease (during this report period Second primary is not a basis for recurrence. See section 10.1 for acceptable criteria for recurrence)
How was recurrence discovered (If yes - select one)
Site of recurrence (If yes - select all that apply)
Was biopsy performed
Biopsy Result (If yes)
Comments

Similar models